// App-Quantinova.ai

SUN-054 : Components of the Metabolic Syndrome in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone

Researchers

Presenter

  • Erica L.T. van den Akker

Principal Investigators

  • Marc B. Bierings

  • Cor van den Bos

  • Christian M. Zwaan

  • Sebastiaan D.T. Sassen

  • Wim J.E. Tissing

  • Margreet A. Veening

  • Rob Pieters

  • Marry M. van den Heuvel-Eibrink

Medical Centers

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Princess Maxima Center, Utrecht, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute lymphoblastic leukemia

  • Metabolic syndrome

Biomarkers

  • Breakpoint Cluster Region

  • Insulin

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved